Bethesda, MD, United States of America

Christian S Hinrichs

This inventor holds 19 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Cancer Immunotherapy. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian S Hinrichs. Retrieved from https://idiyas.com/inventor/christian-s-hinrichs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-Human Papillomavirus
T Cell Receptors
Interleukin-15
Interleukin-21
PDL1 Blockade
TGF-Beta Blockade
HPV+ Malignancies
Cancer Treatment
Immunotherapy
T Cell Preparation
Combination Therapy
Antigen Presentation
19 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christian S. Hinrichs

Introduction

Christian S. Hinrichs is a prominent inventor based in Bethesda, MD, known for his significant contributions to the field of immunology and cancer treatment. With a total of 16 patents to his name, he has made remarkable strides in developing therapies that target human papillomavirus (HPV) and related conditions. His work has the potential to impact the lives of many individuals affected by cancer and HPV infections.

Latest Patents

Hinrichs' latest patents include groundbreaking innovations such as the "Anti-human papillomavirus 16 E6 T cell receptors." This patent discloses a T cell receptor (TCR) that has antigenic specificity for an HLA-A2-restricted epitope of HPV 16 E6. The invention also encompasses related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, and populations of cells. Additionally, it provides methods for detecting and treating conditions in mammals, specifically targeting cancer and HPV-related diseases. Another notable patent is for "Tethered interleukin-15 and interleukin-21," which involves nucleic acids and polypeptides that enable the co-expression of IL-21 and IL-15 by a host cell, each being anchored to the cell membrane. This innovation also includes related pharmaceutical compositions and methods for cancer treatment.

Career Highlights

Throughout his career, Christian S. Hinrichs has worked with esteemed organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His work in these institutions has allowed him to contribute to significant advancements in medical research and therapeutic development.

Collaborations

Hinrichs has collaborated with notable figures in the field, including Steven A. Rosenberg and Benjamin Y. Jin. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in cancer treatment and immunotherapy.

Conclusion

Christian S. Hinrichs stands out as a leading inventor whose work has the potential to transform cancer treatment and improve patient outcomes. His innovative patents and collaborations reflect his commitment to advancing medical science and addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…